Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system.
The topographical model of multiple sclerosis: A dynamic visualization of disease course.
Calcium CaV1 Channel Subtype mRNA Expression in Parkinson's Disease Examined by In Situ Hybridization.
Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Multiple sclerosis and vitamin D: an update.
Autonomic function and brain volume.
Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.
XPC deficiency is related to APE1 and OGG1 expression and function.
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities.
The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.
Effect of Lipopolysaccharide Derived from Pantoea agglomerans on the Phagocytic Activity of Amyloid β by Primary Murine Microglial Cells.
Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway.
Statins: a revised appraisal for potential additional future treatment indications.
Multifocal enlargement and increased vascularization of peripheral nerves detected by sonography in CIDP: A pilot study.
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia.
Modulation of hexadecyl-LPA-mediated activation of mast cells and microglia by a chemical probe of LPA5.
Transfer of folate to the fetus.
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
Neuroprotective Effect of Genistein In Peripheral Nerve Injury.
Selective depletion of CD11c(+) CD11b(+) dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).
Progressive multifocal leukoencephalopathy.
Methods for assessing the regenerative responses of neural tissue.
Pages
« first
‹ previous
…
697
698
699
700
701
702
703
704
705
…
next ›
last »